Adult stem cells in tissue engineering

Expert Review of Medical Devices

Volumn 6, Issue 6, 2009, Pages 621-640

  Hodgkinson, Thomas ^a   Yuan, Xue Feng ^b   Bayat, Ardeshir ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Adipose; Adult stem cell; Bone marrow; Bulge; Hair follicle; Hematopoietic; Mesenchymal; Neural; Tissue engineering

Indexed keywords

NESTIN;

ADIPOSE TISSUE; ADIPOSE TISSUE CELL; ADULT STEM CELL; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE GRAFT; BONE NECROSIS; BONE REGENERATION; CARDIOMYOPATHY; CELL ISOLATION; CLINICAL TRIAL; DIABETIC FOOT; EPITHELIUM CELL; FRACTURE NONUNION; HAIR FOLLICLE; HEART INFARCTION; HEMATOPOIETIC STEM CELL; HUMAN; MELANOCYTE; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOARTHRITIS; REVIEW; SKIN INJURY; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TOOTH PULP;

ADIPOCYTES; ADULT STEM CELLS; ANIMALS; BONE AND BONES; BONE MARROW CELLS; CARTILAGE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; HEMATOPOIETIC STEM CELLS; HUMANS; SKIN; TISSUE ENGINEERING;

EID: 73549115872     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.09.48     Document Type: Review

References (229)

1. Polak JM, Bishop AE. Stem cells and tissue engineering: past, present and future. Ann. NY Acad. Sci. 1068, 352-366 (2006).
2. Frankel MS. In search of stem cell policy. Science 287(5457), 1397 (2000).
3. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663-676 (2006).
4. Pillow RP, Epstein RB, Buckner CD, Giblett ER, Thomas ED. Treatment of bone-marrow failure by isogeneic marrow infusion. N. Engl. J. Med. 275(2), 94-97 (1966).
5. Caplan AI. Mesenchymal stem cells. J. Orthop. Res. 9(5), 641-650 (1991).
6. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st Century. Trends Mol. Med. 7(6), 259-264 (2001).
7. Caterson EJ, Nesti LJ, Danielson KG, Tuan RS. Human marrow-derived mesenchymal progenitor cells. Mol. Biotechnol. 20(3), 245-256 (2002).
8. Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc. Natl Acad. Sci. USA 98(14), 7841-7845 (2001).
9. Friedenstein AJ. Precursor cells of mechanocytes. Int. Rev. Cytol. 47, 327-359 (1976).
10. Grigoriadis AE. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone. J. Cell Biol. 106(6), 2139-2151 (1988).
11. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 284(5411), 143-147 (1999).
12. Prockop DJ, Sekiya I, Colter DC. Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells. Cytotherapy 3(5), 393-396 (2001).
13. Dowthwaite GP, Bishop JC, Redman SN et al. The surface of articular cartilage contains a progenitor cell population. J. Cell Sci. 117(6), 889-897 (2004).
14. Noth U, Osyczka AM, Tuli R, Hickok NJ, Danielson KG, Tuan RS. Multilineage mesenchymal differentiation potential of human trabecular bonederived cells. J. Orthop. Res. 20(5), 1060-1069 (2002).
15. Nakahara H, Bruder SP, Goldberg V, Caplan AI. In vivo osteochondrogenic potential of cultured cells derived from the periosteum. Clin. Orthop. Relat. Res. 259, 223-232 (1990).
16. Nishimura K, Solchaga LA, Caplan AI, Yoo JU, Goldberg VM, Johnstone B. Chondroprogenitor cells of synovial tissue. Arthritis Rheum. 42(12), 2631-2637 (1999).
17. Huard J, Cao B, Qu-Petersen Z. Muscle-derived stem cells: potential for muscle regeneration. Birth Defects Res. C Embryo Today 69(3), 230-237 (2003).
18. Gage FH. Mammalian neural stem cells. Science 287(5457), 1433-1438 (2000).
19. Potten CS. Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philosophical Transactions Royal Soc. B. Biological Sci. 353(1370), 821-830 (1998).
20. Wickham MQ, Erickson GR, Gimble JM, Vail TP, Guilak F. Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin. Orthopaed. Rel. Res. 412, 196-212 (2003).
21. Sen A, Lea-Currie YR, Sujkowska D et al. Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J. Cell Biochem. 81(2), 312-319 (2001).
22. Awad HA, Halvorsen YD, Gimble JM, Guilak F. Effects of transforming growth factor b1 and dexamethasone on the growth and chondrogenic differentiation of adipose-derived stromal cells. Tissue Eng. 9(6), 1301-1312 (2003).
23. Erickson GR, Gimble JM, Franklin DM, Rice HE, Awad H, Guilak F. Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem. Biophys. Res. Commun. 290(2), 763-769 (2002).
24. Gimble JM, Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 5(5), 362-369 (2003).
25. Halvorsen YDC, Bond A, Sen A et al. Thiazolidinediones and glucocorticoids synergistically induce differentiation of human adipose tissue stromal cells: biochemical, cellular, and molecular analysis. Metabolism 50(4), 407-413 (2001).
26. Halvorsen YDC, Franklin D, Bond Al et al. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng. 7(6), 729-741 (2001).
27. Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13(12), 4279 (2002).
28. Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105(3), 369-377 (2001). • Multilineage potential of bone marrow-derived stem cells demonstrated for first time.
29. Gussoni E, Soneoka Y, Strickland CD et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401(6751), 390-394 (1999).
30. Kotton DN, Fine A. Derivation of lung epithelium from bone marrow cells. Cytotherapy 5(2), 169-173 (2003).
31. Petersen BE, Bowen WC, Patrene KD et al. Bone marrow as a potential source of hepatic oval cells. Science 284(5417), 1168(1999).
32. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276(5309), 71 (1997).
33. Terskikh AV, Easterday MC, Li L et al. From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs. Proc. Natl Acad. Sci. 98(14), 7934 (2001).
34. Müller LUW, Daley GQ, Williams DA. Upping the ante: recent advances in direct reprogramming. Mol. Ther. 17(6), 947-953 (2009).
35. Maherali N, Sridharan R, Xie W et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1(1), 55-70 (2007).
36. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448(7151), 313-317 (2007).
37. Wernig M, Meissner A, Foreman R et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448(7151), 318-324 (2007).
38. Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451(7175), 141-146 (2007).
39. Nakagawa M, Koyanagi M, Tanabe K et al. Generation of induced pluripotent stem cells without myc from mouse and human fibroblasts. Nat. Biotechnol. 26(1), 101-106 (2007).
40. Liu H, Zhu F, Yong J et al. Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell 3(6), 587-590 (2008).
41. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G et al. Gene therapy of human severe combined immunodeficiency (scid)-x1 disease. Science 288(5466), 669-672 (2000).
42. Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MM. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 2(7583), 1364-1366 (1968).
43. Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods 45(2), 115-120 (2008).
44. Yeh AT, Kao B, Jung WG, Chen Z, Nelson JS, Tromberg BJ. Imaging wound healing using optical coherence tomography and multiphoton microscopy in an in vitro skin-equivalent tissue model. J. Biomed. Opt. 9(2), 248-253 (2004).
45. Hristov M, Erl W, Weber PC. Endothelial progenitor cells mobilization, differentiation, and homing. Arterioscler. Thromb. Vasc. Biol. 23(7), 1185-1189 (2003).
46. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 241(4861), 58-62 (1988).
47. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273(5272), 242-245 (1996).
48. Mazurier F, Doedens M, Gan OI, Dick JE. Characterization of cord blood hematopoietic stem cells. Ann. NY Acad. Sci. 996, 67-71 (2003).
49. Larochelle A, Vormoor J, Hanenberg H et al. Identification of primitive human hematopoietic cells capable of repopulating nod/scid mouse bone marrow: implications for gene therapy. Nat. Med. 2(12), 1329-1337 (1996).
50. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302), 964-967 (1997).
51. + cells identifies a population of functional endothelial precursors. Blood 95(3), 952-958 (2000).
52. Ito T, Tajima F, Ogawa M. Developmental changes of CD34 expression by murine hematopoietic stem cells. Exp. Hematol. 28(11), 1269-1273 (2000).
53. Sato T, Laver JH, Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood 94(8), 2545-2547 (1999).
54. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human hematopoietic cells with scidrepopulating activity. Nat. Med. 4(9), 1038-1045 (1998).
55. + cells from CD34-hematopoietic cells. Blood 94(12), 4053-4059 (1999).
56. Verfaillie CM. Hematopoietic stem cells for transplantation. Nat. Immunol. 3, 314-317 (2002).
57. + human marrow cells that express low levels of kit protein are enriched for long-term marrow-engrafting cells. Blood 87(10), 4136-4142 (1996).
58. + hematopoietic stem cells (hscs) in multiple myeloma impact of hsc dose on engraftment, safety, and immune reconstitution. Exp. Hematol. 28(7), 858-870 (2000).
59. Goodell MA. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183(4), 1797-1806 (1996).
60. + side population (sp) phenotype. J. Clin. Invest. 108(7), 1071-1077 (2001).
61. Wu KH, Liu YL Zhou B, Han ZC. Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells. Eur. J. Cardiothoracic Surg. 30(5), 770-781 (2006).
62. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19(3), 180-192 (2001).
63. Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found. Symp. 136, 42-60 (1988).
64. Gronthos S, Simmons PJ. The biology and application of human bone marrow stromal cell precursors. J. Hematother. 5(1), 15-23 (1996).
65. Kuznetsov SA, Krebsbach PH, Satomura K et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 12(9), 1335-1347 (1997).
66. Post S, Abdallah BM, Bentzon JF, Kassem M. Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bone marrow-derived mesenchymal stem cells. Bone 43(1), 32-39 (2008).
67. Kastrinaki MC, Sidiropoulos P, Roche S et al. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann. Rheum. Dis. 67(6), 741-749 (2008).
68. Kastrinaki MC, Andreakou I, Charbord P, Papadaki HA. Isolation of human bone marrow mesenchymal stem cells using different membrane markers: comparison of colony/cloning efficiency, differentiation potential, and molecular profile. Tissue Eng. Part C Methods 14(4), 333-339 (2008).
69. Kuznetsov SA, Krebsbach PH, Satomura K et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 12(9), 1335-1347 (1997).
70. Rubio D, Garcia-Castro J, Martin MC et al. Spontaneous human adult stem cell transformation. Cancer Res. 65(8), 3035-3039 (2005).
71. Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp. Hematol. 32(5), 414-425 (2004).
72. Rombouts WJC, Ploemacher RE. Primary murine msc show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 17(1), 160-170 (2003).
73. Togel F, Westenfelder C. Adult bone marrow-derived stem cells for organ regeneration and repair. Dev. Dyn. 236(12), 3321-3331 (2007).
74. Arthur A, Zannettino A, Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J. Cell. Physiol. 218(2), 237-245 (2009).
75. + marrow cell population is multipotential. Cells Tissues Organs 170(2-3), 73-82 (2002). • Identifies Stro-1 as a highly useful marker for multipotent bone marrow-derived stem cells.
76. Coleman SR. Structural fat grafting: more than a permanent filler. Plast. Reconstr. Surg. 118(3S), 108S-120S (2006).
77. Illouz YG. Body contouring by lipolysis: a 5-year experience with over 3000 cases. Plast. Reconstr. Surg. 72(5), 591-597 (1983).
78. Katz AJ, Llull R, Hedrick MH, Futrell JW. Emerging approaches to the tissue engineering of fat. Clin. Plast. Surg. 26(4), 587-603 (1999).
79. Guilak F, Lott KE, Awad HA et al. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J. Cell. Physiol. 206(1), 229-237 (2006). •• Demonstrates that adipose-derived mesenchymal stem cells are multipotent progenitors capable of differentiating along numerous lineages.
80. Lalikos JF, Li YQ, Roth TP, Doyle JW, Matory WE, Lawrence WT. Biochemical assessment of cellular damage after adipocyte harvest. J. Surg. Res. 70(1), 95-100 (1997).
81. Moore JH, Kolaczynski JW, Morales LM et al. Viability of fat obtained by syringe suction lipectomy: effects of local anesthesia with lidocaine. Aesthetic Plast. Surg. 19(4), 335-339 (1995).
82. Oedayrajsingh-Varma MJ, Ham SM, van Knippenberg M et al. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy 8(2), 166-177 (2006).
83. De Ugarte DA, Morizono K, Elbarbary A et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174(3), 101-109 (2003).
84. Gomillion CT, Burg KJL. Stem cells and adipose tissue engineering. Biomaterials 27(36), 6052-6063 (2006).
85. Patrick CW Jr. Adipose tissue engineering: the future of breast and soft tissue reconstruction following tumor resection. Semin. Surg. Oncol. 19(3), 302-311 (2000).
86. Patrick CW Jr. Tissue engineering strategies for adipose tissue repair. Anat. Rec. 263(4), 361-366 (2001).
87. Deans RJ, Moseley AB. Mesenchymal stem cells biology and potential clinical uses. Exp. Hematol. 28(8), 875-884 (2000).
88. Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM. Surface protein characterization of human adipose tissue-derived stromal cells. J. Cell. Physiol. 189(1), 54-63 (2001).
89. Chase HB. Growth of the hair. Physiol. Rev. 34(1), 113-126 (1954).
90. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61(7), 1329-1337 (1990). • Identifies the bulge region of the hair follicle as the location of important stem cell populations.
91. Stenn KS, Combates NJ, Eilertsen KJ et al. Hair follicle growth controls. Dermatol. Clin. 14(4), 543-558 (1996).
92. Lindner G, Botchkarev VA, Botchkareva NV, Ling G, Van Der Veen C, Paus R. Analysis of apoptosis during hair follicle regression (catagen). Am. J. Pathol. 151(6), 1601-1617 (1997).
93. Jahoda CAB. Cell movement in the hair follicle dermis - more than a two-way street? J. Investig. Dermatol. 121(6), 1267-1275 (2003).
94. Richardson GD, Arnott EC, Whitehouse CJ et al. Plasticity of rodent and human hair follicle dermal cells: implications for cell therapy and tissue engineering. J. Investig. Dermatol. Symp. Proc. 10(3), 180-183 (2005)
95. Nishimura EK, Granter SR, Fisher DE. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science 307(5710), 720-724 (2005).
96. Nishimura EK, Jordan SA, Oshima H et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416(6883), 854-860 (2002).
97. Amoh Y, Li L, Campillo R et al. Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves. Proc. Natl Acad. Sci. 102(49), 17734-17738 (2005).
98. Amoh Y, Li L, Katsuoka K, Penman S, Hoffman RM. Multipotent nestin-positive, keratin-negative hair-follicle bulge stem cells can form neurons. Proc. Natl Acad. Sci. 102(15), 5530-5534 (2005).
99. Kruse C, Bodo E, Petschnik AE, Danner S, Tiede S, Paus R. Towards the development of a pragmatic technique for isolating and differentiating nestin-positive cells from human scalp skin into neuronal and glial cell populations: generating neurons from human skin? Exp. Dermatol. 15(10), 794-800 (2006)
100. Kligman AM. The human hair cycle. J. Invest. Dermatol. 33, 307-316 (1959).
101. Pinkus H. Epithelial-mesodermal interaction in normal hair growth, alopecia, and neoplasia. J. Dermatol. 5(3), 93-101 (1978).
102. Oshima H, Rochat A, Kedzia C, Kobayashi K, Barrandon Y. Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell 104(2), 233-245 (2001).
103. Taylor G, Lehrer MS, Jensen PJ, Sun TT, Lavker RM. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 102(4), 451-461 (2000).
104. Nowak JA, Polak L, Pasolli HA, Fuchs E. Hair follicle stem cells are specified and function in early skin morphogenesis. Cell Stem Cell 3(1), 33-43 (2008).
105. Kloepper JE, Tiede S, Brinckmann J et al. Immunophenotyping of the human bulge region: the quest to define useful in situ markers for human epithelial hair follicle stem cells and their niche. Exp. Dermatol. 17(7), 592-609 (2008).
106. Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 118(5), 635-648 (2004).
107. Horsley V, Aliprantis AO, Polak L, Glimcher LH, Fuchs E. Nfatc1 balances quiescence and proliferation of skin stem cells. Cell 132(2), 299-310 (2008).
108. Jaks V, Barker N, Kasper M et al. Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat. Genet. 40(11), 1291-1299 (2008).
109. Merrill BJ, Gat U, Dasgupta R, Fuchs E. Tcf3 and lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev. 15(13), 1688-1705 (2001).
110. Morris RJ, Liu Y, Marles L et al. Capturing and profiling adult hair follicle stem cells. Nat. Biotechnol. 22(4), 411-417 (2004).
111. Nguyen H, Rendl M, Fuchs E. Tcf3 governs stem cell features and represses cell fate determination in skin. Cell 127(1), 171-183 (2006).
112. Rhee H, Polak L, Fuchs E. Lhx2 maintains stem cell character in hair follicles. Science 312(5782), 1946-1949(2006).
113. Tumbar T, Guasch G, Greco V et al. Defining the epithelial stem cell niche in skin. Science 303(5656), 359-363 (2004).
114. Vidal VPI, Chaboissier MC, Lützkendorf S et al. Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment. Curr. Biol. 15(15), 1340-1351 (2005).
115. Jahoda CAB, Reynolds AJ. Hair follicle dermal sheath cells: unsung participants in wound healing. Lancet 358(9291), 1445-1448 (2001).
116. Kumamoto T, Shalhevet D, Matsue H et al. Hair follicles serve as local reservoirs of skin mast cell precursors. Blood 102(5), 1654-1660 (2003).
117. Jahoda CAB, Whitehouse CJ, Reynolds AJ, Hole N. Hair follicle dermal cells differentiate into adipogenic and osteogenic lineages. Exp. Dermatol. 12(6), 849 (2003). • Hair follicle mesenchymal stem cells demonstrated to be capable of adipogenic and osteogenic differentiation, suggesting that hair follicle stem cells could have an important tissue-engineering application.
118. Hoffman RM. Extra view the pluripotency of hair follicle stem cells. Cell Cycle 5(3), 232-233 (2006).
119. Lako M, Armstrong L, Cairns PM, Harris S, Hole N, Jahoda CAB. Hair follicle dermal cells repopulate the mouse haematopoietic system. J. Cell Sci. 115(20), 3967-3974 (2002).
120. Yu H, Fang D, Kumar SM et al. Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am. J. Path. 168(6), 1879-1888 (2006).
121. Hoogduijn MJ, Gorjup E, Genever PG. Comparative characterization of hair follicle dermal stem cells and bone marrow mesenchymal stem cells. Stem Cells Dev. 15(1), 49-60 (2006).
122. Tiede S, Kloepper JE, Bodò E, Tiwari S, Kruse C, Paus R. Hair follicle stem cells: walking the maze. Eur. J. cell Biol. 86(7), 355-376 (2007).
123. Peters EMJ, Botchkarev VA, Botchkareva NV, Tobin DJ, Paus R. Hair-cycleassociated remodeling of the peptidergic innervation of murine skin, and hair growth modulation by neuropeptides. J. Investig. Dermatol. 116(2), 236-245 (2001).
124. Fernandes KJL, Mckenzie LA, Mill P et al. A dermal niche for multipotent adult skin-derived precursor cells. Nat. Cell Biol. 6, 1082-1093 (2004).
125. Sieber-Blum M, Grim M, Hu YF, Szeder V. Pluripotent neural crest stem cells in the adult hair follicle. Dev. Dynamics 231(2), 258-269 (2004).
126. Harada H, Kettunen P, Jung HS, Mustonen T, Wang YA, Thesleff I. Localization of putative stem cells in dental epithelium and their association with notch and fgf signaling. J. Cell Biol. 147(1), 105-120 (1999).
127. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCS) in vitro and in vivo. Proc. Natl Acad. Sci. 97(25), 13625-13630 (2000).
128. Kerkis I, Kerkis A, Dozortsev D et al. Isolation and characterization of a population of immature dental pulp stem cells expressing oct-4 and other embryonic stem cell markers. Cells Tissues Organs 184(3-4), 105-116 (2006).
129. Iohara K, Zheng L, Ito M, Tomokiyo A, Matsushita K, Nakashima M. Side population cells isolated from porcine dental pulp tissue with self-renewal and multipotency for dentinogenesis, chondrogenesis, adipogenesis, and neurogenesis. Stem Cells 24(11), 2493-2503 (2006).
130. Ueno A, Yamashita K, Miyoshi K et al. Soluble matrix from osteoblastic cells induces mineralization by dental pulp cells. J. Med. Invest. 53(3-4), 297-302 (2006).
131. Otaki S, Ueshima S, Shiraishi K et al. Mesenchymal progenitor cells in adult human dental pulp and their ability to form bone when transplanted into immunocompromised mice. Cell Biol. Int. 31(10), 1191-1197 (2007).
132. Shi S, Robey PG, Gronthos S. Comparison of human dental pulp and bone marrow stromal stem cells by cDNA microarray analysis. Bone 29(6), 532-539 (2001).
133. Laino G, Graziano A, D'aquino R et al. An approachable human adult stem cell source for hard-tissue engineering. J. Cell. Physiol. 206(3), 693-701 (2006).
134. Meinel L, Karageorgiou V, Fajardo R et al. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann. Biomed. Eng. 32(1), 112-122 (2004).
135. Sawin PD, Traynelis VC, Menezes AH. A comparative analysis of fusion rates and donor-site morbidity for autogeneic rib and iliac crest bone grafts in posterior cervical fusions. J. Neurosurg. 88(2), 255-265 (1998).
136. Buttermann GR. Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion. Spine J. 8(3), 426-435 (2008).
137. Silber JS, Anderson DG, Daffner SD et al. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 28(2), 134-139 (2003).
138. Lee KJH, Roper JG, Wang JC. Demineralized bone matrix and spinal arthrodesis. Spine J. 5(6S), 217-223 (2005).
139. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J. Orthopaed. Res. 16(2), 155-162 (1998).
140. Krebsbach PH, Mankani MH, Satomura K, Kuznetsov SA, Robey PG. Repair of craniotomy defects using bone marrow stromal cells. Transplantation 66(10), 1272-1278 (1998).
141. Petite H, Viateau V, Bensaïd W et al. Tissue-engineered bone regeneration. Nat. Biotechnol. 18, 959-963 (2000).
142. Kon E, Muraglia A, Corsi A et al. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J. Biomed. Mat. Res. 49(3), 328-337 (2000).
143. Quarto R, Mastrogiacomo M, Cancedda R et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Med. 344(5), 385-386(2001). • Clinical use of autologous bone marrow-derived stem cells to successfully heal large bone defects, with significantly faster healing time than conventional treatment.
144. Marcacci M, Kon E, Moukhachev V et al. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng. 13(5), 947-955 (2007).
145. Velardi F, Amante PR, Caniglia M et al. Osteogenesis induced by autologous bone marrow cells transplant in the pediatric skull. Child's Nervous Sys. 22(9), 1158-1166 (2006).
146. Warnke PH, Springer ING, Wiltfang J et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 364(9436), 766-770 (2004).
147. Ohgushi H, Kotobuki N, Funaoka H et al. Tissue engineered ceramic artificial joint - ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 26(22), 4654-4661 (2005).
148. Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells a pilot study. J. Bone Joint Surg. 86(6), 1153-1160 (2004). • Successful treatment of early-stage osteonecrosis using autologous bone marrow-derived stem cells.
149. Mankani MH, Kuznetsov SA, Fowler B, Kingman A, Gehron Robey P. In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol. Bioeng. 72(1), 96-107 (2001).
150. Chang SC, Tai CL, Chung HY, Lin TM, Jeng LB. Bone marrow mesenchymal stem cells form ectopic woven bone in vivo through endochondral bone formation. Artificial Organs 33(4), 301-308 (2009). • Preliminary use of injectable alginate gel scaffold to produce woven bone. This delivery method is uninvasive and has great potential to reduce infection, operation time and cost.
151. Kakudo N, Shimotsuma A, Miyake S, Kushida S, Kusumoto K. Bone tissue engineering using human adipose-derived stem cells and honeycomb collagen scaffold. J. Biomed. Mater. Res. A 84(1), 191-197 (2008).
152. Hicok KC, Du Laney TV, Zhou YS et al. Human adipose-derived adult stem cells produce osteoid in vivo. Tissue Eng. 10(3-4), 371-380 (2004).
153. Lee JA, Parrett BM, Conejero JA et al. Biological alchemy: engineering bone and fat from fat-derived stem cells. Ann. Plast. Surg. 50(6), 610-617 (2003).
154. Graziano A, d'Aquino R, Laino G, Papaccio G. Dental pulp stem cells: a promising tool for bone regeneration. Stem Cell Rev. 4(1), 65-65 (2008).
155. Chung C, Burdick JA. Engineering cartilage tissue. Adv. Drug Deliv. Rev. 60(2), 243-262 (2007).
156. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 238(1), 265-272 (1998).
157. Coleman RM, Case ND, Guldberg RE. Hydrogel effects on bone marrow stromal cell response to chondrogenic growth factors. Biomaterials 28(12), 2077-2086 (2007).
158. Park KS, Kim SH, Khang G et al. Chondrogenic differentiation of bone marrow stromal cells in transforming growth factor-b1 loaded alginate bead. Macromol. Res. 13(4), 285-292 (2005).
159. Mauck RL, Yuan X, Tuan RS. Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture. Osteoarthr. Cartil. 14(2), 179-189 (2006).
160. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr. Cartil. 10(3), 199-206 (2002).
161. Kuroda R, Ishida K, Matsumoto T et al. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthr. Cartil. 15(2), 226-231 (2007). • Cartilage repaired significantly through the use of bone marrow-derived mesenchymal stem cells, with no adverse effects 5 years after implantation. Demonstrates long-term clinical benefit of bone marrow-derived mesenchymal stem cells.
162. Zuk PA, Zhu M, Mizuno H et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7(2), 211-228 (2001).
163. Chiou M, Xu Y, Longaker MT. Mitogenic and chondrogenic effects of fibroblast growth factor-2 in adipose-derived mesenchymal cells. Biochem. Biophys. Res. Commun. 343(2), 644-652 (2006).
164. Estes BT, Wu AW, Guilak F. Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arthritis Rheum. 54(4), 1222-1232 (2006).
165. Huang JI, Kazmi N, Durbhakula MM, Hering TM, Yoo JU, Johnstone B. Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. J. Orthopaed. Res. 23(6), 1383-1389 (2005).
166. Im GII, Shin YW, Lee KB. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrowderived cells? Osteoarthr. Cartil. 13(10), 845-853 (2005).
167. Winter A, Breit S, Parsch D et al. Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum. 48(2), 418-429 (2003).
168. Betre H, Ong SR, Guilak F, Chilkoti A, Fermor B, Setton LA. Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide. Biomaterials 27(1), 91-99 (2006).
169. Masuoka K, Asazuma T, Hattori H et al. Tissue engineering of articular cartilage with autologous cultured adipose tissue-derived stromal cells using atelocollagen honeycomb-shaped scaffold with a membrane sealing in rabbits. J. Biomed. Mater. Res. Part B Appl. Biomater. 79(1), 25-34 (2006).
170. Wei Y, Hu Y, Hao W et al. A novel injectable scaffold for cartilage tissue engineering using adipose-derived adult stem cells. J. Orthopaed. Res. 26(1), 27-33 (2008).
171. Klein AW, Elson MI. The history of substances for soft tissue augmentation. Dermatologic Surg. 26(12), 1096-1105 (2000).
172. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol. Rev. 78(3), 783-809 (1998).
173. Rodriguez AM, Elabd C, Delteil F et al. Adipocyte differentiation of multipotent cells established from human adipose tissue. Biochem. Biophys. Res. Commun. 315(2), 255-263 (2004).
174. Cui Q, Wang GJ, Balian G. Steroidinduced adipogenesis in a pluripotential cell line from bone marrow. J. Bone Joint Surg. 79(7), 1054-1063 (1997).
175. Neubauer M, Hacker M, Bauer-Kreisel P et al. Adipose tissue engineering based on mesenchymal stem cells and basic fibroblast growth factor in vitro. Tissue Eng. 11(11-12), 1840-1851 (2005).
176. Alhadlaq A, Tang M, Mao JJ. Engineered adipose tissue from human mesenchymal stem cells maintains predefined shape and dimension: implications in soft tissue augmentation and reconstruction. Tissue Eng. 11(3-4), 556-566 (2005).
177. Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem. Rev. 101(7), 1869-1880 (2001).
178. Elisseeff J, Anseth K, Sims D et al. Transdermal photopolymerization of poly (ethylene oxide)-based injectable hydrogels for tissue-engineered cartilage. Plast. Reconstr. Surg. 104(4), 1014-1022 (1999).
179. Jawad H, Ali NN, Lyon AR, Chen QZ, Harding SE, Boccaccini AR. Myocardial tissue engineering: a review. J. Tissue Eng. Regen. Med. 1(5), 327-342 (2007).
180. Makino S, Fukuda K, Miyoshi S et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103(5), 697-705 (1999).
181. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109(3), 337-346 (2002).
182. Shake JG, Gruber PJ, Baumgartner WA et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Soc. Thorac. Surgeons 73(6), 1919-1926 (2002).
183. Nagaya N, Fujii T, Iwase T et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial
184. Nagaya N, Kangawa K, Itoh T et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112(8), 1128-1135 (2005).
185. Shimizu T, Yamato M, Kikuchi A, Okano T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 24(13), 2309-2316 (2003).
186. Miyahara Y, Nagaya N, Kataoka M et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 12, 459-465 (2006).
187. Chen S, Fang W, Ye F et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 94(1), 92-95 (2004).
188. Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the boost randomised controlled clinical trial. Lancet 364(9429), 141-148 (2004).
189. Katritsis DG, Sotiropoulou PA, Karvouni E et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter. Cardiovasc. Interv. 65(3), 321-329 (2005).
190. Meyer GP, Wollert KC, Lotz J et al. Intracoronary bone marrow cell transfer after myocardial infarction. Eighteen months' follow-up data from the randomized, controlled boost (bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation. 113(10), 1287-1294 (2006).
191. Penicka M, Horak J, Kobylka P et al. Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction a prematurely terminated randomized study. J. Am. Coll. Cardiol. 49(24), 2373-2374 (2007).
192. Lunde K, Solheim S, Aakhus S et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355(12), 1199-1209 (2006).
193. Kraitchman DI, Tatsumi M, Gilson WD et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112(10), 1451-1461 (2005).
194. Hofmann M, Wollert KC, Meyer GP et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111(17), 2198-2202 (2005).
195. Hou D, Youssef EA-S, Brinton TJ et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery, implications for current clinical trials. Circulation 112, I150-I156 (2005).
196. Poh M, Boyer M, Solan A et al. Blood vessels engineered from human cells. Lancet 365(9477), 2122-2124 (2005).
197. Seruya M, Shah A, Pedrotty D et al. Clonal population of adult stem cells: life span and differentiation potential. Cell Transplant 13, 93-101 (2004).
198. Kinner B, Zaleskas JM, Spector M. Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Exp. Cell Res. 278(1), 72-83 (2002).
199. Ball SG, Shuttleworth AC, Kielty CM. Direct cell contact influences bone marrow mesenchymal stem cell fate. Intl J. Biochem. Cell Biol. 36(4), 714-727 (2004).
200. Gong Z, Niklason LE. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (HMSCS). FASEB J. 22(6), 1635-1648 (2008).
201. Macneil S. Progress and opportunities for tissue-engineered skin. Nature 445(7130), 874-880 (2007).
202. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6(3), 331-343 (1975).
203. Lenoir MC, Bernard BA, Pautrat G, Darmon M, Shroot B. Outer root sheath cells of human hair follicle are able to regenerate a fully differentiated epidermis in vitro. Dev. Biol. 130(2), 610-620 (1988).
204. Gharzi A, Reynolds AJ, Jahoda CAB. Plasticity of hair follicle dermal cells in wound healing and induction. Exp. Dermatol. 12(2), 126-136 (2003).
205. Michel M, L'Heureux N, Pouliot R, Xu W, Auger FA, Germain L. Characterization of a new tissue-engineered human skin equivalent with hair. In Vitro Cell. Dev. Biol. Anim. 35(6), 318-326 (1999).
206. Wang HT, Chen B, Tang CW, Hu DH. Primary observation on construction of skin with human hair follicle bulge cells with tissue engineering technique. Zhonghua Shao Shang Za Zhi. 23(3), 222-224 (2007).
207. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J. Immunol. 180(4), 2581-2587 (2008).
208. Wu C, Hughes PE, Ginsberg MH, Mcdonald JA. Identification of a new biological function for the integrin a v b 3: initiation of fibronectin matrix assembly. Cell Adhes. Commun. 4(3), 149-158 (1996).
209. Kataoka K, Medina RJ, Kageyama T et al. Participation of adult mouse bone marrow cells in reconstitution of skin. Am. J. Pathol. 163(4), 1227-1231 (2003).
210. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J. Leukoc. Biol. 69(4), 513-521 (2001).
211. Shumakov VI, Onishchenko NA, Rasulov MF, Krasheninnikov ME, Zaidenov VA. Mesenchymal bone marrow stem cells more effectively stimulate regeneration of deep burn wounds than embryonic fibroblasts. Bull. Exp. Biol. Med. 136(2), 192-195 (2003).
212. Mansilla E, Marin GH, Sturla F et al. Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries. Transplant Proc. 37(1), 292-294 (2005).
213. Liu H, Kemeny DM, Heng BC, Ouyang HW, Melendez AJ, Cao T. The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells. J. Immunol. 176(5), 2864-2871 (2006).
214. Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25(10), 2648-2659 (2007).
215. Lataillade JJ, Doucet C, Bey E et al. New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen. Med. 2(5), 785-794 (2007).
216. Vojtassak J, Danisovic L, Kubes M et al. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro endocrinol. Lett. 27, 134-137 (2006). • Use of bone marrow-derived mesenchymal stem cells to treat diabetic foot ulcers. Importantly, stem cell use was reported to increase vascularization of the patients dermis.
217. Spees JL, Olson SD, Ylostalo J et al. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc. Natl Acad. Sci. 100(5), 2397-2402 (2003).
218. + ckit- cells cocultured with fetal liver cells into hepatic-like cells without fusion. Exp. Hematol. 34(1), 97-106 (2006).
219. Abdallah BM, Kassem M. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives. J. Cell. Physiol. 218(1), 9-12 (2009).
220. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 52(8), 2521-2529 (2005).
221. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24(5), 1294-1301 (2006).
222. Estes BT, Gimble JM, Guilak F. Mechanical signals as regulators of stem cell fate. Stem Cells Dev. Dis. 60, 91-126 (2004).
223. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 126(4), 677-689 (2006).
224. Kinnaird T, Stabile E, Burnett MS et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94(5), 678-685 (2004).
225. Hung SC, Pochampally RR, Chen SC, Hsu SC, Prockop DJ. Angiogenic effects of human multipotent stromal cell conditioned medium activate the pi3k-akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 25(9), 2363-2370 (2007).
226. Klyushnenkova E, Mosca JD, Zernetkina V et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J. Biomed. Sci. 12(1), 47-57 (2005).
227. Morishita T, Honoki K, Ohgushi H, Kotobuki N, Matsushima A, Takakura Y. Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients' mesenchymal stem cells. Artificial Organs 30(2), 115-118 (2006).
228. Lendeckel S, Jödicke A, Christophis P et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J. Cranio-Maxillofacial Surg. 32(6), 370-373 (2004).
229. Falanga V, Iwamoto S, Chartier M et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 13(6), 1299-1312 (2007).